Halfdanarson TR - Search Results

1

Biomarkers for prognosis in pancreatic neuroendocrine tumors.

Zhu M, Sorenson KR, Liu R, Gould Rothberg BE, Halfdanarson TR. Zhu M, et al. Among authors: halfdanarson tr. Endocr Relat Cancer. 2021 Oct 19;28(12):773-782. doi: 10.1530/ERC-21-0075. Endocr Relat Cancer. 2021. PMID: 34582360

2

Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Halfdanarson TR, et al. Endocr Relat Cancer. 2008 Jun;15(2):409-27. doi: 10.1677/ERC-07-0221. Endocr Relat Cancer. 2008. PMID: 18508996 Free PMC article. Review.

3

Obesity adversely affects survival in pancreatic cancer patients.

McWilliams RR, Matsumoto ME, Burch PA, Kim GP, Halfdanarson TR, de Andrade M, Reid-Lombardo K, Bamlet WR. McWilliams RR, et al. Among authors: halfdanarson tr. Cancer. 2010 Nov 1;116(21):5054-62. doi: 10.1002/cncr.25465. Cancer. 2010. PMID: 20665496 Free PMC article.

4

Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution.

Engelman ES, Leon-Ferre R, Naraev BG, Sharma N, Sun S, O'Dorisio TM, Howe J, Button A, Zamba G, Halfdanarson TR. Engelman ES, et al. Among authors: halfdanarson tr. Pancreas. 2014 Mar;43(2):219-25. doi: 10.1097/MPA.0000000000000030. Pancreas. 2014. PMID: 24518499 Free PMC article.

5

Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.

Curran T, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N. Curran T, et al. Among authors: halfdanarson tr. J Gastrointest Surg. 2015 Jan;19(1):152-60; discussion 160. doi: 10.1007/s11605-014-2624-z. Epub 2014 Aug 14. J Gastrointest Surg. 2015. PMID: 25118642

6

Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.

Halfdanarson TR, Bamlet WR, McWilliams RR, Hobday TJ, Burch PA, Rabe KG, Petersen GM. Halfdanarson TR, et al. Pancreas. 2014 Nov;43(8):1219-22. doi: 10.1097/MPA.0000000000000234. Pancreas. 2014. PMID: 25291526 Free PMC article.

7

Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies.

Halfdanarson TR, Strosberg JR. Halfdanarson TR, et al. Curr Clin Pharmacol. 2015;10(4):305-10. doi: 10.2174/1574884710666151020100211. Curr Clin Pharmacol. 2015. PMID: 26548907 Review.

8

Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver.

Keutgen XM, Schadde E, Pommier RF, Halfdanarson TR, Howe JR, Kebebew E. Keutgen XM, et al. Among authors: halfdanarson tr. Semin Oncol. 2018 Aug;45(4):232-235. doi: 10.1053/j.seminoncol.2018.07.002. Epub 2018 Oct 11. Semin Oncol. 2018. PMID: 30318110 Review.

9

Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors.

Ramage J, Naraev BG, Halfdanarson TR. Ramage J, et al. Among authors: halfdanarson tr. Semin Oncol. 2018 Aug;45(4):236-248. doi: 10.1053/j.seminoncol.2018.08.004. Epub 2018 Oct 24. Semin Oncol. 2018. PMID: 30539715 Free article. Review.

10

The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.

Xie H, Liu J, Yadav S, Keutgen XM, Hobday TJ, Strosberg JR, Halfdanarson TR. Xie H, et al. Among authors: halfdanarson tr. Neuroendocrinology. 2020;110(3-4):234-245. doi: 10.1159/000501126. Epub 2019 May 24. Neuroendocrinology. 2020. PMID: 31121586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters